|
|
|
|
|
ABELCET 
|
Fever and chills may occur 1 to 2 hours after the infusion is started. This is more common with the first few doses and should subside as therapy continues. Nausea, head ache and irritation at the injection site may also occur. To help minimize this effec
|
|
 |
|
 |
| |
Currently there are no comments or questions written by any user on "ABELCET". You can be the First one to write one.
|
|
 |
|
 |
|
|
|
|
Wida seal diaphragm
, Thara-plus
, Pronastyl
, Lax-pils
, Sesame stret vit wextra c
, Ecular
, Flutamida
, Padiazole
, Mastinon
, Saw palmeto
|
|
|
|
|
| Latest News About Abelcet |
|
|
|
|
|
|
|
domain-B, India - 8 May 2008
Post spin-off, Enzon will retain the current marketed products of Abelcet, Adagen, DepoCyt and Oncaspar, the rights to current PEG royalty revenues, ... |
|
|
|
|
The Star-Ledger - NJ.com, NJ - 7 May 2008
The company's core specialty pharmaceutical business -- which markets such products as the cancer drug Oncaspar and Abelcet, a treatment for invasive fungal ...
|
|
|
|
|
FOXBusiness - 24 Apr 2008
Enzon has a portfolio of four marketed products, Oncaspar(R), DepoCyt(R), Abelcet(R) and Adagen(R). The Company's drug development programs utilize several ...
|
|
|
|
|
MSN Money - 7 May 2008
Following the spin-off of the biotechnology company, Enzon will retain the current marketed products of Abelcet, Adagen, DepoCyt and Oncaspar, the rights to ...
|
|
|
|
|
|
|
|
|
